GLASF (Glass House Brands) Receivables Turnover: 7.16 (As of Mar. 2026)


GLASF Glass House Brands Inc GLASF
44 GF Score
Price $12.21
GF Value $6.13
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Glass House Brands Receivables Turnover?

Glass House Brands GLASF -4.16% 44 Receivables Turnover is 7.16 as of Mar. 2026. GuruFocus rates GLASF with a GF Score™ of 44/100 and a GF Value™ of $6.13 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 945 Drug Manufacturers companies, Glass House Brands ranks better than 97.04% on this metric.

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Glass House Brands's Revenue for the three months ended in Mar. 2026 was $38.9 Mil. Glass House Brands's average Accounts Receivable for the three months ended in Mar. 2026 was $5.4 Mil. Hence, Glass House Brands's Receivables Turnover for the three months ended in Mar. 2026 was 7.16.


Glass House Brands  (OTCPK:GLASF) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.


Glass House Brands Receivables Turnover Related Terms


Glass House Brands Receivables Turnover Historical Data

* Premium members only.

The historical data trend for Glass House Brands's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Glass House Brands Receivables Turnover Chart

Glass House Brands Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Receivables Turnover
Get a 7-Day Free Trial 16.62 23.40 36.69 43.67 37.76

Glass House Brands Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Receivables Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.51 7.23 4.81 7.36 7.16

GLASF vs ZTS: Receivables Turnover Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Glass House Brands's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Glass House Brands Receivables Turnover vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Glass House Brands's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Glass House Brands's Receivables Turnover falls into.


GLASF
44GF Score
Glass House Brands Inc GLASF
Receivables Turnover is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Glass House Brands Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Glass House Brands's Receivables Turnover for the fiscal year that ended in Dec. 2025 is calculated as

Receivables Turnover (A: Dec. 2025 )
=Revenue / Average Accounts Receivable
=Revenue (A: Dec. 2025 ) / ((Accounts Receivable (A: Dec. 2024 ) + Accounts Receivable (A: Dec. 2025 )) / count )
=181.984 / ((5.221 + 4.417) / 2 )
=181.984 / 4.819
=37.76

Glass House Brands's Receivables Turnover for the quarter that ended in Mar. 2026 is calculated as

Receivables Turnover (Q: Mar. 2026 )
=Revenue / Average Accounts Receivable
=Revenue (Q: Mar. 2026 ) / ((Accounts Receivable (Q: Dec. 2025 ) + Accounts Receivable (Q: Mar. 2026 )) / count )
=38.855 / ((4.417 + 6.441) / 2 )
=38.855 / 5.429
=7.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Receivables Turnover →
What does a Receivables Turnover of 7.16 mean?
Glass House Brands (GLASF) has a Receivables Turnover of 7.16 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Glass House Brands and its competitors. According to the industry distribution chart, Glass House Brands ranks #28 out of 945 companies in the Drug Manufacturers industry, placing it in the top 3%.
Is Glass House Brands' Receivables Turnover too high?
Glass House Brands' current Receivables Turnover is 7.16. The Drug Manufacturers industry median Receivables Turnover is 5.07. Glass House Brands' value of 7.16 is 41.2% above this industry median. Based on the distribution chart, Glass House Brands ranks #28 out of 945 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Glass House Brands has a GF Score™ of 44/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Glass House Brands' Receivables Turnover compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Glass House Brands ranks #28 out of 945 companies for Receivables Turnover. This places Glass House Brands in the top 3% of its industry — outperforming the majority of peers. The industry median Receivables Turnover is 5.07. Glass House Brands' value of 7.16 is 41.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Drug Manufacturers company?
The median Receivables Turnover among Drug Manufacturers companies is 5.07, based on 945 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Glass House Brands's current Receivables Turnover of 7.16 is 41.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Glass House Brands and its competitors. For the Drug Manufacturers industry, the median Receivables Turnover is 5.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Glass House Brands's current Receivables Turnover is 7.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Glass House Brands stock overvalued right now?
Based on GuruFocus' analysis, Glass House Brands (GLASF) is currently considered Significantly Overvalued. The stock's GF Value™ is $6.13, compared to a current price of $12.21 — trading 99.2% above its estimated fair value. The current Receivables Turnover is 7.16 and 41.2% above the Drug Manufacturers industry median of 5.07. Glass House Brands' overall GF Score™ is 44/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Glass House Brands (GLASF), the current Receivables Turnover is 7.16 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Glass House Brands (GLASF) Overvalued in 2026?

Based on GuruFocus' analysis, Glass House Brands stock appears to be overvalued. The current stock price of $12.21 is trading 99.2% above its estimated GF Value™ of $6.13. GuruFocus considers Glass House Brands to be Significantly Overvalued.

Key valuation signals for GLASF:

  • Receivables Turnover: 7.16
  • GF Value™: $6.13 vs. price of $12.21 (99.2% above fair value)
  • GF Score™: 44/100 with 4 warning signs
  • Industry Position: 41.2% above the Drug Manufacturers median (#28 of 945)

No single metric tells the full story. See the GLASF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Glass House Brands Business Description

Other Exchanges 4KF0:GermanyGLAS.A.U:Canada
Address 3645 Long Beach Boulevard, Long Beach, CA, USA, 90807
Glass House Brands Inc is an integrated cannabis company that operates exclusively in the state of California. Its portfolio of brands includes Glass House Farms, Forbidden Flowers, and Mama Sue Wellness. It cultivates, manufactures, and distributes cannabis bulk flower and trim to wholesalers and consumer packaged goods to third-party retail stores. It also owns and operates retail cannabis stores in the state of California. It has three reportable segments: Retail, Wholesale Biomass, and Cannabis-related consumer packaged goods. It generates the majority of its revenue from the Wholesale Biomass segment.
44GF Score

Get the complete analysis for GLASF

Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$12.21
Price
$6.13
GF Value